The global Precision Medicine market size is estimated to generate revenues of more than USD 141.33 billion by 2027, growing at a CAGR of around 11.5% from 2021 to 2027
The report covers SWOT analysis, market valuation, competitive spectrum,
regional share, and revenue predictions. The
report offers an analysis of the global Precision Medicine Market for the period
2016 to 2027, wherein 2021 to 2027 is the forecast period and 2020 is
considered as the base year.
The wide application portfolio of Precision Medicine market is one of
factors driving the growth of market worldwide. The global market is moderately
competitive with a blend of global and regional players. The markets key
players invest significantly in R and D to enhance their offerings. The entire
ecosystem is composed of multiple participants. Every participant of the
ecosystem is an equal contributor to the growth of global market.
Why should you
invest in this report?
If you are aiming to enter the global Precision Medicine
Market, this report is a comprehensive guide that provides crystal clear
insights into this niche market. All the major application areas for Precision
Medicine are covered in this report and information is given on the important
regions of the world where this market is likely to boom during the forecast
period of 2021-2027, so that you can plan your strategies to enter this market
accordingly. Besides, through this report, you can have a complete grasp of the
level of competition you will be facing in this hugely competitive market and
if you are an established player in this market already, this report will help
you gauge the strategies that your competitors have adopted to stay as market
leaders in this market. For new entrants to this market, the voluminous data
provided in this report is invaluable.
Download the Sample Pages of this
Research Report@ https://www.precedenceresearch.com/sample/1085
Report Structure:
- pertinent
market numbers of the global Precision Medicine market along with the CAGR
for the forecast period 2021-2027
- detailed
definitions of different types of Precision Medicine, which gives clarity
about what this market is all about and also defines the scope of this
report
- macroeconomic
factors influencing the global Precision Medicine market, along with
market opportunity analysis
- key
trends likely to impact the global Precision Medicine market
- PESTLE
analysis of all the regions as per the market taxonomy
- Porter’s
Five Force Analysis of all the regions as given in the market taxonomy
Global market analysis and forecast:
- the
global Precision Medicine market analysis and forecast by product type, by
application, by region and others
- key
market metrics such as the BPS analysis, year-on-year growth rates,
absolute dollar opportunity and market attractiveness analysis of the
global Precision Medicine market
Regional market analysis and forecast:
- Regional
Precision Medicine market analysis and forecast
- Regional
market dynamics including the drivers, restraints and trends applicable
across different regions in the Precision Medicine market along with
factors encouraging the growth of this market as well as the factors hampering
the growth of this market
- Regional
trends – both long term and short term
Get Customization
on this Research Report@ https://www.precedenceresearch.com/customization/1085
Competitive landscape:
- the
competitive landscape of this global report
- information
on the various leading companies in the global market
- a
dashboard view of the key companies operating in the global market along
with their important information and broad strategy adopted to stay as
leaders in the global market
- key
company profiles along with important information such as company details,
company description, product portfolio along with key developments
concerning the company and strategic analysis
Some of the prominent players in Precision
Medicine market include:
- Biocrates
Life Sciences
- Tepnel
Pharma Services
- Novartis
- Qiagen
- Quest
Diagnostics
- Menarini
Silicon Biosystems
- NanoString
Technologies
- Eagle
Genomics
- Pfizer
- Intomics
- Roche
- Teva
Pharmaceutical
Market Segmentation:
By Technology
- Bioinformatics
- Big
Data Analytics
- Drug
Discovery
- Gene
Sequencing
- Companion
Diagnostics
- Others
By Application
- CNS
- Immunology
- Oncology
- Respiratory
- Others
By End-Use
- Diagnostic
Companies
- Pharmaceutical
Companies
- Healthcare
IT companies
- Others
By Regional Outlook
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia
Pacific
- China
- India
- Japan
- South
Korea
- Rest
of the World
Research Methodology
In this report, historical data, primary responses and public
domain data has been thoroughly analyzed to infer the market size. Revenue of
companies operating in the global market has been benchmarked to ascertain the
market size for the base year. Macroeconomic indicators such as GDP and industry
growth have been considered to determine the market size for the forecast
period. The historical growth trend of end-use industries, market participants’
performance, as well as the present macro-economic outlook has been taken into
consideration for estimating the overall market trend forecast. This data is
then validated using the triangulation method and extensively scrutinized using
advanced tools to garner quantitative and qualitative insights into the global Precision
Medicine.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Precision Medicine Market, By Technology
7.1. Precision Medicine Market, by Technology Type, 2020-2027
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Companion Diagnostics
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Precision Medicine Market, By Application
8.1. Precision Medicine Market, by Application, 2020-2027
8.1.1. CNS
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Immunology
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Oncology
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Precision Medicine Market, By End-Use
9.1. Precision Medicine Market, by End-Use, 2020-2027
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Precision Medicine Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End-Use (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End-Use (2016-2027)
Chapter 11. Company Profiles
11.1. Biocrates Life Sciences
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Tepnel Pharma Services
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Novartis
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Qiagen
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Quest Diagnostics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Menarini Silicon Biosystems
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. NanoString Technologies
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eagle Genomics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Pfizer
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Intomics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Roche
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Teva Pharmaceutical
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Complete
the Payment and Get the Full Access of this Report@ https://www.precedenceresearch.com/checkout/1085
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 comments:
Post a Comment